Anatomy of CytoDyn’s CEO Financing – Selfless Act to Save Countless Lives
Financing Ensures COVID-19 Drug Availability
Read Moreby Pat Monarch | May 4, 2020 | Companies, Covid-19 Coronavirus, Pharmaceutical, Research, Viruses | 7 |
Financing Ensures COVID-19 Drug Availability
Read Moreby Pat Monarch | Feb 18, 2020 | Cancer, Companies, Drug Trial, Pharmaceutical, Research | 5 |
The Quest for a Functional Cure in Cancer Reaching an Inflection Point The recent clinical trial...
Read Moreby Steve Kanaval | Jan 27, 2020 | Pharmaceutical, Viruses | 0 |
Forth Worth, Texas, January 27, 2020 (MarketNewsFirst) — Experts say they knew it was...
Read Moreby Mike Sheikh | Jan 3, 2020 | Cancer, Companies, Drug Trial, Pharmaceutical | 0 |
Cytodyn Inc (CYDY) recently announced it was going to move forward with a Breakthrough Therapy...
Read Moreby Mike Sheikh | Nov 25, 2019 | Cancer, Companies, Drug Trial, Pharmaceutical | 0 |
Diffusion Pharmaceuticals Inc. (DFFN) has a current market cap of $7.6 million, but on a fully...
Read Moreby Mike Sheikh | Nov 23, 2019 | Alternative Treatments, Companies, Pharmaceutical | 0 |
Trading in AV1 Group (AVOP) reached a climax after the company filed their latest quarterly report...
Read MoreShare with: